Acasti to Present at the Life Sciences Investor Forum View Press Release
Acasti Pharma Inc.
Transforming the Treatment for an Acute Brain Injury
Acasti is poised to disrupt the long-established standard of care in aneurysmal subarachnoid hemorrhage (aSAH) — a rare, life-threatening disease caused by the rupture of an aneurysm deep inside the brain.
Learn More About GTX-104